Power Luke Thomas 4

What Happened
Power Luke Thomas, Senior Vice President, Chief Financial Officer and Chief Accounting Officer of Caris Life Sciences (CAI), received an award of 63,971 restricted stock units (RSUs) on March 6, 2026. The Form 4 reports the acquisition at $0.00 per share (code A — award/grant), so the transaction is a compensation award rather than a cash purchase.

Key Details

• Transaction date: 2026-03-06 (reported on Form 4 filed 2026-03-10).
• Transaction type/code: Award/Grant (A) — 63,971 RSUs @ $0.00 (acquired).
• Reported dollar value for the transaction on the form: $0.
• Footnote: F1 — these are restricted stock units that vest in accordance with the applicable grant agreement.
• Shares owned after transaction: Not specified in the provided filing.
• Filing timeliness: Form filed March 10, 2026 reporting a March 6 transaction; the filing provided does not indicate a late-report flag in the data shown here.

Context
RSU grants are a form of equity compensation and typically vest over time per the grant agreement; they are not an immediate market purchase or sale. Such awards are common for executive compensation and do not by themselves indicate insider buying or selling sentiment.